Immunostimulatory activity of CpG containing phosphorothioate oligodeoxynucleotide is modulated by modification of a single deoxynucleoside.

[1]  Gunther Hartmann,et al.  Mechanism and Function of a Newly Identified CpG DNA Motif in Human Primary B Cells1 , 2000, The Journal of Immunology.

[2]  S. Agrawal,et al.  Site of chemical modifications in CpG containing phosphorothioate oligodeoxynucleotide modulates its immunostimulatory activity. , 1999, Bioorganic & medicinal chemistry letters.

[3]  J. Kline,et al.  CpG oligodeoxynucleotides do not require TH1 cytokines to prevent eosinophilic airway inflammation in a murine model of asthma. , 1999, The Journal of allergy and clinical immunology.

[4]  G. Hartmann,et al.  Mechanisms and therapeutic applications of immune stimulatory cpG DNA. , 1999, Pharmacology & therapeutics.

[5]  Lin Chen,et al.  Oligodeoxynucleotides containing CpG motifs can induce rejection of a neuroblastoma in mice. , 1999, Cancer research.

[6]  L. Manzel,et al.  Lack of immune stimulation by immobilized CpG-oligodeoxynucleotide. , 1999, Antisense & nucleic acid drug development.

[7]  H. Davis,et al.  CpG DNA as mucosal adjuvant. , 1999, Vaccine.

[8]  L. Manzel,et al.  Antagonism of immunostimulatory CpG-oligodeoxynucleotides by quinacrine, chloroquine, and structurally related compounds. , 1998, Journal of immunology.

[9]  S. Agrawal,et al.  Pattern and kinetics of cytokine production following administration of phosphorothioate oligonucleotides in mice. , 1997, Antisense & nucleic acid drug development.

[10]  S. Agrawal,et al.  Effect of different chemically modified oligodeoxynucleotides on immune stimulation. , 1996, Biochemical Pharmacology.

[11]  G. Bishop,et al.  CpG motifs in bacterial DNA trigger direct B-cell activation , 1995, Nature.

[12]  D. Pisetsky,et al.  Stimulation of murine lymphocyte proliferation by a phosphorothioate oligonucleotide with antisense activity for herpes simplex virus. , 1994, Life sciences.

[13]  R. Branda,et al.  Immune stimulation by an antisense oligomer complementary to the rev gene of HIV-1. , 1993, Biochemical pharmacology.